• Thiothixene: Typical Antipsychotic Agent Unlocks Efferocytos

  2026-07-28

  Thiothixene stands out not only as a typical antipsychotic agent, but also as a novel macrophage efferocytosis enhancer. This dual-function profile empowers researchers to bridge neuropsychiatric and immunological applications with robust protocol guidance and troubleshooting strategies.

• ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-07-28

  This study identifies ETS1 as a key regulator of mitophagy in bronchopulmonary dysplasia (BPD) through modulation of the SENP2/HSPA8/FUNDC1 axis. By revealing a novel transcriptional pathway that maintains mitochondrial homeostasis, the research provides new insights for targeted interventions in neonatal lung disease.

• Meropenem Trihydrate in Resistance Studies: Protocols & Insi

  2026-07-27

  Meropenem trihydrate empowers researchers to dissect carbapenem resistance and accelerate infection model workflows with quantifiable precision. This article delivers stepwise protocols, advanced troubleshooting, and translational insight from cutting-edge metabolomics, making it indispensable for antibiotic resistance and infection research.

• Dietary Arachidonic Acid Enhances Humoral Immunity: Insights

  2026-07-27

  The referenced study demonstrates that dietary arachidonic acid (ARA) supplementation markedly accelerates and amplifies vaccine-induced humoral immunity in both mice and humans. These findings highlight the immunomodulatory potential of omega-6 polyunsaturated fatty acids, opening new avenues for optimizing vaccine efficacy and prompting further investigation into related molecules such as gamma-linolenic acid (GLA) in anti-inflammatory and immune research.

• Hoechst 33342/PI Double Staining Kit: Practical Workflow Gui

  2026-07-26

  The Hoechst 33342/PI Double Staining Kit addresses the need for reliable discrimination between apoptotic and necrotic cells in fluorescence-based cell death assays. It is suitable for basic research workflows requiring chromatin condensation and membrane integrity assessment, but is not intended for diagnostic or clinical applications.

• Proteomic Mechanisms of Platycodin D-Induced Apoptosis in NS

  2026-07-25

  This study employs multidimensional proteomics to elucidate how Platycodin D triggers apoptosis in non-small cell lung cancer by binding RFC4 and disrupting Notch signaling. The findings offer a mechanistic platform for targeted apoptosis-inducing strategies and enable rational design of future epigenetic and proteomic workflows.

• Prostaglandin E2 in Immunity: Advanced Mechanisms & Applicat

  2026-07-24

  Explore how Prostaglandin E2 (PGE2) orchestrates immune regulation, linking lipid metabolism to humoral immunity and advanced research applications. This article uniquely deciphers recent breakthroughs and offers practical guidance for leveraging PGE2 in translational workflows.

• Comparative Antibacterial Activity of β-Lactam Derivatives i

  2026-07-24

  The reference study systematically compares the antibacterial activities of N-formimidoyl thienamycin (MK0787) with other advanced β-lactam antibiotics, focusing on resistant clinical isolates. Its key innovation is the robust cross-species benchmarking, revealing spectrum strengths and limitations against Gram-negative and Gram-positive bacteria, including ampicillin-resistant strains. These findings inform antibiotic selection and resistance research protocols.

• Aclacinomycin A: Applied Workflows for DNA Damage & Apoptosi

  2026-07-23

  Aclacinomycin A (Aclarubicin) stands out for its dual topoisomerase inhibition, enabling high-fidelity DNA damage and apoptosis modeling in cancer research. This guide translates cutting-edge reference findings into actionable protocols, advanced applications, and troubleshooting strategies for robust, reproducible results.

• AMPK–SQSTM1 Feedback Loop Dual-Activates Antioxidant Defense

  2026-07-23

  This study reveals a double-positive feedback loop between AMPK and SQSTM1/p62, driving the dual activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings clarify how tumor cells coordinate antioxidant defenses, with significant implications for research on metabolic adaptation and targeted cancer therapies.

• Palonosetron Hydrochloride in CINV: Evidence and Oncology Co

  2026-07-22

  The reference study by Ruhlmann and Herrstedt systematically examines palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV). The paper highlights the unique pharmacological properties and superior efficacy of palonosetron, particularly in managing both acute and delayed CINV, compared to earlier antiemetic agents, informing best practices for supportive care in oncology research.

• L-Alanyl-L-Glutamine: Protocol Optimization for GI Barrier S

  2026-07-22

  L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide) delivers unmatched stability and reproducibility for gastrointestinal barrier and infection models. This guide unpacks applied workflows, troubleshooting tactics, and cross-study innovations to help researchers maximize data quality and translational impact.

• GSH-Responsive MOF Nanoparticles for Synergistic Melanoma Th

  2026-07-21

  Hao et al. developed a glutathione-responsive metal-organic framework (MOF) nanoparticle platform, combining indocyanine green and a PD-1 inhibitory peptide for synergistic photothermal and immunotherapy against melanoma. This dual-action nanomedicine approach promises improved tumor ablation and targeted immune activation, offering new strategies for melanoma management.

• Prostaglandin E2 in Inflammation Research: Protocols & Pitfa

  2026-07-21

  Prostaglandin E2 (PGE2) is a cornerstone of inflammation and immune regulation research, offering unmatched specificity via EP receptor targeting. This guide translates cutting-edge findings and proven workflows into actionable solutions, ensuring reproducibility and maximizing translational impact with APExBIO’s high-purity PGE2.

• Enhanced Generation of Pancreatic Ductal Organoids via Small

  2026-07-20

  This study introduces an optimized protocol using small molecule cocktails to significantly improve the efficiency and stability of pancreatic ductal organoid (PDO) generation. The findings provide an advanced, reproducible model for studying pancreatic diseases and drug screening, addressing limitations of prior organoid systems.

555 records 10/37 page Previous Next First page 上5页 678910 下5页 Last page